PARIS (Reuters) – France will take a stake in Sanofi (NASDAQ:)’s Opella by the Public Funding Financial institution (BPI), finance minister Antoine Armand mentioned on Sunday, confirming an data from Le Figaro newspaper that U.S. personal fairness agency Clayton Dubilier & Rice (CD&R) is to take a 51% stake within the firm that makes of one in all France’s most-sold painkillers, Doliprane.
The plan for Public Funding Financial institution (BPI) to take a 1% stake in Opella, for about 150 million euros ($162.98 million), got here by a tri-party settlement between Sanofi, the French state and CD&R and was authorized by Sanofi’s board on Sunday, the newspaper mentioned.
Finance minister Antoine Armand had mentioned earlier this week that the federal government was taking a look at all choices concerning Opella, together with the state being on Opella’s board of administrators.
($1 = 0.9204 euros)